Cytomegalovirus strains resistant to gancyclovir;Cepas de citomegalovirus resistentes a ganciclovir

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 17, Issue 7, 1999, Pages 330-334

  Calicó, Ignacio ^a   García, Esther ^a   Cortés, Alberto ^a   Gavaldá, Joan ^a   Roman, Antonio ^a   Valle, Inés ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Acyclovir; Cytomegalovirus; Gancyclovir; Resistance; Resistance to gancyclovir

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; GANCICLOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CHILD; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; ORGAN TRANSPLANTATION; STRAIN DIFFERENCE; VIRUS INFECTION; VIRUS INHIBITION;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA-DIRECTED DNA POLYMERASE; DRUG RESISTANCE, MICROBIAL; FEMALE; FETAL DISEASES; GANCICLOVIR; GENES, VIRAL; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; MALE; MATERNAL-FETAL EXCHANGE; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); POSTOPERATIVE COMPLICATIONS; PREGNANCY; TRANSPLANTATION; TREATMENT OUTCOME; VIRAL PROTEINS; VIRAL STRUCTURAL PROTEINS; WEGENER GRANULOMATOSIS;

EID: 0032762433     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Dunn JM, MacCumber MW, Forman MS, Charache P, Apuzzo L, Jabs DA. Viral sensitivity testing in patients with cytomegalovirus retinitis clinically resistant to foscarnet or ganciclovir. Am J Ophthalmol 1995; 119: 587-596.
2. Erice A, Chou S, Biron KK, Stanat SC, Balfour HH, Jordan C. Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients. N Engl J Med 1989; 320: 289-293.
3. Boivin G, Chou S, Quirk MR, Erice A, Jordan C. Detection of ganciclovir resistance mutations and quantitation of cytomegalovirus (CMV) DNA in leukocytes of patients with fatal disseminated CMV disease. J Infect Dis 1996; 173: 523-528.
4. Dieterich DT, Poles MA, Lew EA, Méndez PE, Murphy R, Addessi A et al. Concurrent use of ganciclovir and foscarnet to treat cytomegalovirus infection in AIDS patients. J Infect Dis 1993; 167: 1.184-1.188.
5. Desatnik HR, Foster RE, Lowder CY. Treatment of clinically resistant cytomegalovirus retinitis with combined intravitreal injections of ganciclovir and foscarnet. Am J Ophthalmol 1996; 122: 121-123.
6. Chou S, Marousek G, Parenti DM, Gordon SM, La Voy AG, Ross JG et al. Mutation in region III of the DNA polymerase gene conferring foscarnet resistance in cytomegalovirus isolates from 3 subjects receiving prolonged antiviral therapy. J Infect Dis 1998; 178: 526-530.
7. Cohen AT, O'Grady JG, Sutherland S, Sallie R, Tan KC, Williams R. Controlled trial of prophylactic versus therapeutic use of ganciclovir after liver transplantation in adults. J Med Virol 1993; 40: 5-9.
8. Schmidt GM, Horack DA, Niland JC, Duncan SR, Forman SJ, Zaia JA et al. A randomize, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection disease after allogeneic bone marrow transplantation. N Engl J Med 1991; 324: 1.005-1.011.
9. Erice A, Borrell N, Li W, Miller WJ, Balfour Jr HH. Ganciclovir susceptibilities and analysis of UL97 region in cytomegalovirus (CMV) isolates from bone marrow recipients with CMV disease after antiviral prophylaxis. J Infect Dis 1998; 178: 531-534.
10. Wolf DG, Yaniv I, Honigman A, Kassis I, Schonfeld T, Ashkenazi S. Early emergence of ganciclovir-resistanct human cytomegalovirus strains in children with primary combined immunodeficiency. J Infect Dis 1998: 178: 535-538.
11. Calicó I, Balada E, Cortés Borra A, Mercader E. A simplified technique for determining the sensitivity of cytomegalovirus strains to ganciclovir. J Virol Methods 1996; 60: 59-64.
12. Laguarda M, González Fuente T, Calicó I. Sensibilidad del citomegalovirus a los antivirales. Estudio preliminar. Rev Esp Quimioterap 1993. 6: 301-303.
13. Baldanti F, Simoncini L, Sarasini A, Zavattoni M, Grossi P, Revello MG et al. Ganciclovir resistance as a result of oral ganciclovir in a heart transplant recipient with multiple human cytomegalovirus strains in blood. Transplantation 1998; 66: 324-329.
14. Slavin MA, Bindra RR, Gleaves CA, Pettinger MB, Bowden RA. Ganciclovir sensitivity of citomegalovirus at diagnosis and during treatment of cytomegalovirus pneumonia in marrow transplant recipients. Antimicrob Agents Chemother 1993; 37: 1.360-1.363.
15. Chou S, Guentzel S, Michels KR, Miner RC, Drew WL. Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates. J Infect Dis 1995; 172: 239-242.
16. Gerna G, Sarasini A, Percivalle E, Zavattoni M, Baldanti F, Revello MG. Rapid screening for resistance to ganciclovir and foscarnet of primary isolates of human cytomegalovirus from culture-positive blood samples. J Clin Microbiol 1995; 33: 738-741.
17. Chou S, Erice A, Jordan MC, Vercellotti GM, Michels KR, Talarico CL et al. Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance. J Infect Dis 1995; 171: 576-583.
18. Hanson MN, Preheim LC, Chou S, Talarico CL, Biron KK, Erice A. Novel mutation in the UL97 gene of a clinical cytomegalovirus strain conferring resistance to ganciclovir. Antimicrob Agents Chemother 1995; 39: 1.204-1.205.
19. Baldanti F, Silini E, Sarasini A, Talarico CL, Stanat SC, Biron KK et al. A three-nucleotide deletion in trie UL97 open reading frame is responsible for the ganciclovir resistance of a human cytomegalovirus clinical isolate. J Virol 1995; 69: 796-800.
20. Smith IL, Shinkai M, Freeman WR, Spector SA Polyradiculopathy associated with ganciclovir-resistance cytomegalovirus in an AIDS patient: phenotypic and genotypic characterization of sequential virus isolates. J Infect Dis 1996; 173: 1.481-1.484.
21. Baldanti F, Sarasini A, Silini E, Barbi M, Lazzarin A, Biron KK et al. Four dually resistant human cytomegalovirus strains from AIDs patients: single mutations in UL97 and UL54 open reading frames are responsible for ganciclovir- and foscarnet-specific resistance, respectively. Scand J Infect Dis 1995; (Supl 99): 103-104.
22. Tatarowicz WA, Lurain NS, Thompson KD. A ganciclovir-resistant clinical isolate of human cytomegalovirus eshibiting cross-resistance to other DNA polymerase inhibitors. J Infect Dis 1992; 166: 904-907.
23. Wolf DG, Lee DJ, Spector SA Detection of human cytomegalovirus mutations associated with ganciclovir resistance in cerebrospinal fluid of AIDS patients with central nervous system disease. Antimicrob Agents Chemother 1995; 39: 2.552-2.554.